Drug Injury Watch

Side Effects News & Reports

From 2005 to the Present

All Articles by Tom Lamb

Tag: Merck

Fosamax MDL Judge Keenan Wants Two More Bellwether Case Trials: February 4, 2011 Order

February 8, 2011

In Addition To The Federal Court Fosamax Jaw Injury Lawsuits Set For Trial In March 2011 And May 2011 (Posted by Tom Lamb at DrugInjuryWatch.com)_____________________________________________________________________ UPDATE: Order by Federal Court Fosamax MDL Judge John F. Keenan…
Continue reading…
Zocor Label Change: Interstitial Lung Disease (ILD) Added As Possible Adverse Reaction

November 15, 2010

November 2010 FDA Approval Of Merck Action Raises Profile Of This Emerging Drug Safety Issue (Posted by Tom Lamb at DrugInjuryWatch.com) As we reported recently, the October 2010 issue of the Canadian Adverse Reaction…
Continue reading…
Graves v. Merck Fosamax MDL Trial Begins After Pre-trial Motions Rulings By Judge Keenan

November 2, 2010

Merck Issues Its "No Liability" Press Release On First Day Of Trial; 1092 Fosamax Lawsuits Filed As Of June 2010 (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: Merck Not at Fault in Fosamax…
Continue reading…
Graves v. Merck Fosamax MDL Trial Jury Verdict Is Expected By End Of November 2010

September 30, 2010

Two More Fosamax Lawsuits Involving Jaw Injury Like Osteonecrosis Of The Jaw (ONJ) Will Go To Trial In Spring 2011 (Posted by Tom Lamb at DrugInjuryWatch.com) _______________________________________________________________________________ UPDATE: Merck Not at Fault in Fosamax Trial, Jurors Say …
Continue reading…
Fosamax Femur Fracture Warning Label Change By Merck Seems Likely After Task Force Report

September 16, 2010

FDA Considering Issue Due To September 2010 American Society of Bone And Mineral Research Report About Bisphosphonate Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: FDA Drug Safety Communication: Safety update for…
Continue reading…
Boles v. Merck Fosamax Trial Jury Verdict Is $8 Million For Plaintiff In June 2010

June 26, 2010

This Was A Retrial Of The First Fosamax MDL Case, Which Ended When Judge Declared Mistrial Back In September 2009 (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: Merck Fosamax Verdict Cut to $1.5 Million…
Continue reading…
Focus On Fosamax

March 12, 2010

________________________________________________________ Free Fosamax Case Evaluation The information you provide to us for this Free Case Evaluation will be treated as strictly confidential. You will get a reply from us no later than the next business…
Continue reading…
February 2010: Fosamax Federal Court MDL Litigation Update; Next Trial Starts In Mid-April

February 2, 2010

Merck Lost Its Attempt To Have Louise Maley's Fosamax Lawsuit Dismissed Before Her April 19, 2010 Trial Date (Posted by Tom Lamb at DrugInjuryWatch.com) We have been reporting about the three bellwether trial cases…
Continue reading…
FDA Wants Merck To Change Januvia Label With Increased Warning About Pancreatitis Risk

September 29, 2009

Is Januvia Similar To Byetta In Terms Of The So-Called Class Effect And Drug Injury Lawsuits Being Filed? (Posted by Tom Lamb at DrugInjuryWatch.com) On September 25, 2009 the FDA posted on its web…
Continue reading…
Drug Industry Document Archive Has Over 1500 Documents Regarding Big Pharma Conduct

September 11, 2009

Includes Previously Secret Documents That Were Released During Lawsuits Against Merck & Co., Parke-Davis, Warner-Lambert, and Pfizer (Posted by Tom Lamb at DrugInjuryWatch.com) The Drug Industry Document Archive (DIDA), created by the University of…
Continue reading…